Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Nanotechnology Based Approaches for Tuberculosis Treatment discusses multiple nanotechnology-based approaches that may help overcome persisting limitations of conventional and traditional treatments. The book summarizes the types of nano drugs, their synthesis, formulation, characterization and applications, along with the most important administration routes. It also explores recent advances and achievements regarding therapeutic efficacy and provides possible future applications in this field. It will be a useful resource for investigators, pharmaceutical researchers, innovators and scientists working on technology advancements in the areas of targeted therapies, nano scale imaging systems, and diagnostic modalities in tuberculosis.
- Addresses the gap between nanomedicine late discovery and early development of tuberculosis therapeutics
- Explores tuberculosis nanomedicine standardization and characterization with newly developed treatment, diagnostic and treatment monitoring modalities
- Covers the field thoroughly, from the pathogenesis of tuberculosis and multi-drug resistant mycobacterium tuberculosis, to treatment approaches using nanotechnology and different nanocarriers
Researchers, early-career investigators, and graduate students working in the pharmaceutical industries, nanomedicine, or infectious diseases
- Pathogenesis, biology, and immunology of tuberculosis
RAVI BANDARU, DEVIPRASAD SAHOO, RAMAKANTA NAIK, PRASHANT KESHARWANI AND RAMBABU DANDELA
2. Tuberculosis: introduction, drug regimens, and multidrug-resistance
SIMA SINGH, NEELAM DHANKAR, ASHISH KUMAR GARG AND PRASHANT KESHARWANI
3. Nanotechnology as a potential tool against drug- and multidrug-resistant tuberculosis
DAMIÁN EDUARDO PÉREZ-MARTÍNEZ AND ROBERTO ZENTENO-CUEVAS
4. Translational research for therapy against tuberculosis
YOLANDA GONZALEZ, SILVIA GUZMÁN-BELTRÁN, LAURA E. CARRETO-BINAGHI AND ESMERALDA JUÁREZ
5. Vaccine delivery systems against tuberculosis
RUPAL OJHA, RAJAN KUMAR PANDEY AND VIJAY KUMAR PRAJAPATI
6. Inhalable polymeric dry powders for antituberculosis drug delivery
SUNEERA ADLAKHA, KALPESH VAGHASIYA, ANKUR SHARMA, EUPA RAY AND RAHUL KUMAR VERMA
7. Liposomes-and niosomes-based drug delivery systems for tuberculosis treatment
ALI IBRAHIM BEKRAKI
8. Polymer-based nanoparticles as delivery systems for treatment and vaccination of tuberculosis
MOHSEN TAFAGHODI, FARZAD KHADEMI, FARIDEH SHIEHZADEH AND ZOHREH FIROZI
9. Nanotechnology-based approaches for tuberculosis treatment
MOHAMAD MOSA MUBARAK AND ZAHOOR AHMAD
10. Dendrimer-based drug delivery systems for tuberculosis treatment
RAHUL SHUKLA, AAKRITI SETHI, MAYANK HANDA, MRADUL MOHAN, PRASHANT KESHARWANI AND PUSHPENDRA K. TRIPATHI
11. Polymeric micelle-based drug delivery systems for tuberculosis treatment
BAPI GORAIN, HIRA CHOUDHURY, SREENIVAS PATRO AND PRASHANT KESHARWANI
12. Nanostructured lipid carrier-based drug delivery systems for tuberculosis treatment
SIMONE PINTO CARNEIRO AND ORLANDO DAVID HENRIQUE DOS SANTOS
13. DNA markers and nano-biosensing approaches for tuberculosis diagnosis
AMAL RABTI, AMAL RAOUAFI AND NOUREDDINE RAOUAFI
14. Recent advancement and future perspective for the treatment of multidrug-resistant tuberculosis
Noorsuzana Mohd Shariff
15. Nanotechnology approach in conquering anti-TB resistance
- No. of pages:
- © Academic Press 2020
- 19th June 2020
- Academic Press
- Paperback ISBN:
Dr. Prashant Kesharwani is Assistant Professor at Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He received his doctoral degree in Pharmaceutical Sciences from the Dr H.S. Gour University (Sagar, India) with Prof N.K Jain’s group. After his doctorate, he worked as postdoctoral fellows in the Wayne State University, Detroit (Michigan, USA). Dr. Kesharwani subsequently joined the School of Pharmacy, International Medical University (Malaysia) as lecturer in Pharmaceutical Technology. Subsequently he joined Central Drug Research Institute (CDRI), Lucknow as Ramanujan Fellow. He is a recipient of several internationally acclaimed awards. He has also received many research grants from various funding agencies of Government of India (GoI) i.e. Science and Engineering Research Board (SERB), Indian Council of Medical Research (ICMR), and University Grants Commission (UGC). An overarching goal of his current research is the development of nano-engineered drug delivery systems for cancer through with prime focus on dendrimer and polymeric nanomicelles mediated drug delivery systems. Dr. Kesharwani is a co-author on more than 140 publications in high impact factor international journals and 7 international books with total citations of more than 5000 (h index is 36 and i-10 index is 92 as per Google Scholar).
Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.